Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Open Study of Safety and Preliminary Efficiency of the Drug "Efesovir" (Oral Solution) for Coronavirus Infection (COVID-19)

NCT05060705 is registered in ClinicalTrials.gov with Scientific Center for Anti-infectious Drugs, Kazakhstan as lead sponsor.

NCT NCT05060705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05060705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Open Study of Safety and Preliminary Efficiency of the Drug "Efesovir" (Oral Solution) for Coronavirus Infection (COVID-19)
Lead sponsor
Scientific Center for Anti-infectious Drugs, Kazakhstan
Phase
Phase 2
Overall status
Not yet recruiting
Start date
December 31, 2025
Completion date
November 30, 2026
Enrollment
62 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19